Paradigm Biopharma

AU: PAR

Market Cap£392m

Last Close 1.4p

Paradigm Biopharmaceuticals is a commercially-focused drug development company.

More Paradigm Biopharma content > View more
Register to receive research on Paradigm Biopharma as it is published
Share price graph
Price performance
%
1m
3m
12m
Actual 4.5 10.2 (34.1)
Relative* (2.1) 6.6 (33.0)
52-week high/low 2.1p/0.9p
*% relative to local index